Form 4: Callan JMB Inc. Executive David J. Croyle Increases Stake with $112,500 Stock Purchase

David J. Croyle, Chief Medical Officer and a 10% owner of Callan JMB Inc., acquired 25,000 shares of common stock for $4.50 per share on March 27, 2025, increasing his indirect holdings through a Rollover IRA.

Summary

• On March 27, 2025, David J. Croyle, Chief Medical Officer and a 10% owner of Callan JMB Inc. (CJMB), purchased 25,000 shares of the company's common stock.
• The shares were acquired at a price of $4.50 per share, totaling $112,500.
• The transaction was executed under transaction code 'P', indicating a purchase on the open market.
• Following the transaction, Croyle's indirectly held beneficial ownership increased to 775,000 shares through a Rollover IRA.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The purchase by an executive is generally a good sign, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• An insider purchase can be seen as a positive signal, indicating the executive's confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into a company's performance and management's sentiment. A purchase by a key executive like the Chief Medical Officer is often viewed positively.

Stakeholder Impact

• The increased stake by a key executive could boost investor confidence.

Key Dates

Keywords

insider trading, Form 4, beneficial ownership, stock purchase, Callan JMB Inc., CJMB, Croyle, Rollover IRA